癌症研究
肿瘤微环境
腺苷
免疫系统
幽门螺杆菌
细胞毒性T细胞
肥大细胞
腺苷受体
CD38
化学
下调和上调
分泌物
癌症
细胞毒性
胃粘膜
T细胞
生物
肿瘤进展
免疫学
受体
细胞生物学
白细胞介素33
胃
细胞
癌细胞
细胞内
炎症
药理学
前列腺素E
前列腺素D2
前列腺素E2
作者
Jiabao Zhao,Deyi Feng,Fan Zhang,Shuntian Cai,Yubo Xiong,Guangchao Pan,Jingsong Ma,Jinshui Tan,Mengya Zhong,Zeyang Lin,Yifan Zhuang,Wei Wang,Huiwen Zhou,Shengyi Zhou,Ao Cheng,Meijuan Xu,Wenjie Ye,Hangzi Chen,Yongxi Song,Zhenning Wang
出处
期刊:Cell Reports
[Cell Press]
日期:2026-01-23
卷期号:45 (2): 116863-116863
被引量:2
标识
DOI:10.1016/j.celrep.2025.116863
摘要
Helicobacter pylori ( H . pylori ) infection is the primary driver in gastric cancer (GC) development, but the dynamic changes of the gastric mucosal microenvironment during H . pylori -associated GC progression remains elusive. Here, we perform single-cell RNA sequencing (scRNA-seq) on 21 gastric mucosae collected from four typical stages of GC progression under H . pylori infection. Our scRNA-seq analysis delineates the cellular landscape, dissects the dynamic alterations, and characterizes distinct immune cell populations. Notably, H . pylori -associated activated mast cells upregulate CD38 and COX2 expression, leading to increased secretion of adenosine and prostaglandin E 2 (PGE 2 ). PGE 2 enhances adenosine receptor expression in CD8 + T cells, thereby suppressing their cytotoxicity via adenosine signaling. Cellular interactions are more complex at the GC stage than in the premalignant lesions. Collectively, our study offers a comprehensive insight into the evolving gastric mucosal microenvironment and validates the pro-tumor role of activated mast cells under H . pylori infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI